Who owns QUALIGEN THERAPEUTICS INC?
- Ticker: QLGN
- CUSIP Number: 74754r301
Tip: Access positions for across all investors
Analyze quarterly positions in Qualigen Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Qualigen Therapeutics stock
Who bought or sold QUALIGEN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cubist Systematic Strategies | 28k | $160k | 100% | Sep 2025 |
|
| UBS Group | 3.2k | $18k | 100% | Sep 2025 |
|
| BlackRock | 501.00 | $2.9k | -2% | Sep 2025 |
|
| Tower Research Capital | 413.00 | $2.4k | -65% | Sep 2025 |
|
| Harbour Investments | 325.00 | $1.9k | 0% | Sep 2025 |
|
| Stone House Investment Management | 200.00 | $1.1k | 100% | Sep 2025 |
|
| HighMark Wealth Management | 160.00 | $915.008000 | 0% | Sep 2025 |
|
| Group One Trading | 8.00 | $46.000000 | 0% | Sep 2025 |
|
| Us Bancorp | 7.00 | $40.000100 | 0% | Sep 2025 |
|
| UMA Financial Services | 2.00 | $12.000000 | 0% | Sep 2025 |
|
| SBI Securities | 1.00 | $6.000000 | 0% | Sep 2025 |
|
| Danske Bank A/s | 1.00 | $6.000000 | 100% | Sep 2025 |
|
Who sold out of Qualigen Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| LLBH Private Wealth Management | Jun 2025 | 10k | $34k |
| FNY Investment Advisers | Mar 2025 | 7.5k | $27k |
| Raymond James Financial | Jun 2025 | 30.00 | $102.000000 |